SK284339B6 - Deriváty pyridopyranoazepínu, spôsob ich prípravy, liečivo a farmaceutická kompozícia s ich obsahom - Google Patents
Deriváty pyridopyranoazepínu, spôsob ich prípravy, liečivo a farmaceutická kompozícia s ich obsahom Download PDFInfo
- Publication number
- SK284339B6 SK284339B6 SK1242-2001A SK12422001A SK284339B6 SK 284339 B6 SK284339 B6 SK 284339B6 SK 12422001 A SK12422001 A SK 12422001A SK 284339 B6 SK284339 B6 SK 284339B6
- Authority
- SK
- Slovakia
- Prior art keywords
- group
- alkyl
- hydrogen
- compound
- carbon atoms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Rheumatology (AREA)
- Hospice & Palliative Care (AREA)
- Anesthesiology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Saccharide Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9902784A FR2790474B1 (fr) | 1999-03-05 | 1999-03-05 | Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique |
PCT/FR2000/000502 WO2000053608A1 (fr) | 1999-03-05 | 2000-03-01 | Derives de pyridopyranoazepines, leur preparation et leur application en therapeutique |
Publications (2)
Publication Number | Publication Date |
---|---|
SK12422001A3 SK12422001A3 (sk) | 2002-04-04 |
SK284339B6 true SK284339B6 (sk) | 2005-02-04 |
Family
ID=9542888
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1242-2001A SK284339B6 (sk) | 1999-03-05 | 2000-03-01 | Deriváty pyridopyranoazepínu, spôsob ich prípravy, liečivo a farmaceutická kompozícia s ich obsahom |
Country Status (37)
Country | Link |
---|---|
US (2) | US6538003B1 (id) |
EP (1) | EP1161434B1 (id) |
JP (1) | JP4806123B2 (id) |
KR (2) | KR100768355B1 (id) |
CN (1) | CN1137894C (id) |
AR (1) | AR022820A1 (id) |
AT (1) | ATE231869T1 (id) |
AU (1) | AU764625B2 (id) |
BG (1) | BG65211B1 (id) |
BR (1) | BR0008763A (id) |
CA (1) | CA2372063C (id) |
CO (1) | CO5160250A1 (id) |
CZ (1) | CZ302259B6 (id) |
DE (1) | DE60001307T2 (id) |
DK (1) | DK1161434T3 (id) |
EE (1) | EE04497B1 (id) |
ES (1) | ES2191611T3 (id) |
FR (1) | FR2790474B1 (id) |
HK (1) | HK1040398B (id) |
HR (1) | HRP20010655B1 (id) |
HU (1) | HU228671B1 (id) |
ID (1) | ID30116A (id) |
IL (2) | IL145150A0 (id) |
MX (1) | MXPA01008972A (id) |
NO (1) | NO327119B1 (id) |
NZ (1) | NZ513561A (id) |
PE (1) | PE20001543A1 (id) |
PL (1) | PL201683B1 (id) |
RS (1) | RS49997B (id) |
RU (1) | RU2238273C2 (id) |
SK (1) | SK284339B6 (id) |
TR (1) | TR200102403T2 (id) |
TW (1) | TWI222975B (id) |
UA (1) | UA61164C2 (id) |
UY (1) | UY26048A1 (id) |
WO (1) | WO2000053608A1 (id) |
ZA (1) | ZA200106811B (id) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10164139A1 (de) | 2001-12-27 | 2003-07-10 | Bayer Ag | 2-Heteroarylcarbonsäureamide |
BR0312297A (pt) | 2002-07-18 | 2005-04-12 | Cytos Biotechnology Ag | Conjugados veìculos de hapteno e seu uso |
US7238715B2 (en) * | 2002-12-06 | 2007-07-03 | The Feinstein Institute For Medical Research | Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists |
CA2507502C (en) * | 2002-12-06 | 2011-11-29 | North Shore-Long Island Jewish Research Institute | Inhibition of inflammation using alpha 7 receptor-binding cholinergic agonists |
US8580842B2 (en) * | 2003-09-30 | 2013-11-12 | Abbott Gmbh & Co. Kg | Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them |
US8316104B2 (en) | 2005-11-15 | 2012-11-20 | California Institute Of Technology | Method and apparatus for collaborative system |
US8486979B2 (en) * | 2006-12-12 | 2013-07-16 | Abbvie Inc. | 1,2,4 oxadiazole compounds and methods of use thereof |
US20080167286A1 (en) | 2006-12-12 | 2008-07-10 | Abbott Laboratories | Pharmaceutical compositions and their methods of use |
UY30846A1 (es) | 2006-12-30 | 2008-07-31 | Abbott Gmbh & Amp | Derivados de oxindol sustituidos, medicamentos que los comprenden y uso de los mismos |
US20080255203A1 (en) * | 2007-04-12 | 2008-10-16 | Abbott Laboratories | Heterocyclic compounds and their methods of use |
US20090076059A1 (en) * | 2007-09-19 | 2009-03-19 | Protia, Llc | Deuterium-enriched dianicline |
WO2010009775A1 (de) | 2007-12-07 | 2010-01-28 | Abbott Gmbh & Co. Kg | Carbamat-substituierte oxindol-derivate und ihre verwendung zur behandlung von vasopressin-abhängigen erkrankungen |
BRPI0820668A2 (pt) * | 2007-12-07 | 2017-08-22 | Abbott Gmbh & Co Kg | Derivados de oxindol substituídos por 5-halogênio e seu uso para tratar doenças dependentes de vasopressina |
US8703775B2 (en) * | 2007-12-07 | 2014-04-22 | AbbVie Deutschland GmbH & Co. KG | Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses |
CN102026995B (zh) * | 2007-12-07 | 2014-10-29 | Abbvie德国有限责任两合公司 | 5,6-二取代的羟吲哚衍生物和其用途 |
US8383657B2 (en) * | 2007-12-21 | 2013-02-26 | Abbott Laboratories | Thiazolylidine urea and amide derivatives and methods of use thereof |
US20090221648A1 (en) * | 2007-12-21 | 2009-09-03 | Abbott Laboratories | Compositions for treatment of cognitive disorders |
JP2011516489A (ja) | 2008-03-31 | 2011-05-26 | ユニバーシティ・オブ・サウス・フロリダ | 疾患誘発性運動失調症および非運動失調性平衡異常の治療法 |
ES2396300T3 (es) | 2008-11-19 | 2013-02-20 | Envivo Pharmaceuticals, Inc. | Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma |
TW201031664A (en) | 2009-01-26 | 2010-09-01 | Targacept Inc | Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)-3,5-difluorobenzamide |
CN102802620A (zh) * | 2009-05-11 | 2012-11-28 | 英维沃医药有限公司 | 使用某种α-7烟酸受体与乙酰胆碱酯酶抑制剂结合治疗认知障碍 |
US9040568B2 (en) * | 2009-05-29 | 2015-05-26 | Abbvie Inc. | Pharmaceutical compositions for the treatment of pain |
WO2011146511A1 (en) | 2010-05-17 | 2011-11-24 | Envivo Pharmaceuticals, Inc. | A crystalline form of (r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide hydrochloride monohydrate |
AU2013259871A1 (en) | 2012-05-08 | 2014-11-20 | Forum Pharmaceuticals Inc. | Methods of maintaining, treating or improving cognitive function |
US9585867B2 (en) | 2015-08-06 | 2017-03-07 | Charles Everett Ankner | Cannabinod formulation for the sedation of a human or animal |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9301660D0 (en) * | 1993-01-28 | 1993-03-17 | Smithkline Beecham Plc | Pharmaceuticals |
JPH11512443A (ja) * | 1995-09-22 | 1999-10-26 | ノボ ノルディスク アクティーゼルスカブ | 新規な置換アザ環式またはアザ二環式化合物 |
FR2761072B1 (fr) * | 1997-03-20 | 1999-04-23 | Synthelabo | Derives de 2,3-dihydrofuro[3,2-b]pyridine, leur preparation et leur application en therapeutique |
ATE254618T1 (de) * | 1997-05-30 | 2003-12-15 | Neurosearch As | Spiro chinuclidin-derivate, ihre herstellung und verwendung |
AR013184A1 (es) * | 1997-07-18 | 2000-12-13 | Astrazeneca Ab | Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis |
SE9900100D0 (sv) * | 1999-01-15 | 1999-01-15 | Astra Ab | New compounds |
-
1999
- 1999-03-05 FR FR9902784A patent/FR2790474B1/fr not_active Expired - Fee Related
-
2000
- 2000-01-03 UA UA2001085808A patent/UA61164C2/uk unknown
- 2000-03-01 CN CNB008046662A patent/CN1137894C/zh not_active Expired - Fee Related
- 2000-03-01 DK DK00907746T patent/DK1161434T3/da active
- 2000-03-01 HU HU0201753A patent/HU228671B1/hu not_active IP Right Cessation
- 2000-03-01 NZ NZ513561A patent/NZ513561A/xx not_active IP Right Cessation
- 2000-03-01 US US09/913,679 patent/US6538003B1/en not_active Expired - Lifetime
- 2000-03-01 ID IDW00200101796A patent/ID30116A/id unknown
- 2000-03-01 CA CA2372063A patent/CA2372063C/en not_active Expired - Fee Related
- 2000-03-01 ES ES00907746T patent/ES2191611T3/es not_active Expired - Lifetime
- 2000-03-01 DE DE60001307T patent/DE60001307T2/de not_active Expired - Lifetime
- 2000-03-01 CZ CZ20013102A patent/CZ302259B6/cs not_active IP Right Cessation
- 2000-03-01 KR KR1020017011245A patent/KR100768355B1/ko not_active IP Right Cessation
- 2000-03-01 AT AT00907746T patent/ATE231869T1/de active
- 2000-03-01 JP JP2000604044A patent/JP4806123B2/ja not_active Expired - Fee Related
- 2000-03-01 EE EEP200100470A patent/EE04497B1/xx not_active IP Right Cessation
- 2000-03-01 PL PL352330A patent/PL201683B1/pl unknown
- 2000-03-01 EP EP00907746A patent/EP1161434B1/fr not_active Expired - Lifetime
- 2000-03-01 RS YUP-596/01A patent/RS49997B/sr unknown
- 2000-03-01 TR TR2001/02403T patent/TR200102403T2/xx unknown
- 2000-03-01 RU RU2001123126/04A patent/RU2238273C2/ru not_active IP Right Cessation
- 2000-03-01 MX MXPA01008972A patent/MXPA01008972A/es unknown
- 2000-03-01 KR KR1020077013746A patent/KR20070086359A/ko not_active Application Discontinuation
- 2000-03-01 WO PCT/FR2000/000502 patent/WO2000053608A1/fr not_active Application Discontinuation
- 2000-03-01 CO CO00014724A patent/CO5160250A1/es unknown
- 2000-03-01 SK SK1242-2001A patent/SK284339B6/sk not_active IP Right Cessation
- 2000-03-01 IL IL14515000A patent/IL145150A0/xx active IP Right Grant
- 2000-03-01 BR BR0008763-7A patent/BR0008763A/pt not_active Application Discontinuation
- 2000-03-01 AU AU29226/00A patent/AU764625B2/en not_active Ceased
- 2000-03-03 AR ARP000100942A patent/AR022820A1/es active IP Right Grant
- 2000-03-03 UY UY26048A patent/UY26048A1/es not_active IP Right Cessation
- 2000-03-03 PE PE2000000187A patent/PE20001543A1/es not_active Application Discontinuation
- 2000-03-08 TW TW089103753A patent/TWI222975B/zh not_active IP Right Cessation
-
2001
- 2001-08-16 BG BG105828A patent/BG65211B1/bg unknown
- 2001-08-17 ZA ZA200106811A patent/ZA200106811B/en unknown
- 2001-08-28 IL IL145150A patent/IL145150A/en not_active IP Right Cessation
- 2001-09-03 NO NO20014270A patent/NO327119B1/no not_active IP Right Cessation
- 2001-09-05 HR HR960321A patent/HRP20010655B1/xx not_active IP Right Cessation
-
2002
- 2002-03-07 HK HK02101759.7A patent/HK1040398B/zh not_active IP Right Cessation
-
2003
- 2003-02-06 US US10/359,881 patent/US6908927B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK284339B6 (sk) | Deriváty pyridopyranoazepínu, spôsob ich prípravy, liečivo a farmaceutická kompozícia s ich obsahom | |
TWI221843B (en) | Derivatives 1,4-diazabicyclo[3.2.2]nonane-4-carboxylates and carboxamides, their preparation and their therapeutic application | |
PL172852B1 (pl) | Nowe pochodne piperydyny i sposób wytwarzania nowych pochodnych piperydyny PL PL | |
SK6772002A3 (en) | New use and novel n-azabicyclo-amide derivatives | |
TW200303312A (en) | 4-(Oxadiazol-3-yl)-1,4-diazabicyclo[3.2.2]nonane derivatives, their preparation and their application in therapeutics | |
US6835730B2 (en) | 4-heteroparyl-1,4-diazabicyclo[3.2.2]nonane, preparation and therapeutic use thereof | |
WO2004043960A1 (en) | 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof | |
KR101830447B1 (ko) | 7-([1,2,4]트리아졸로[1,5-α]피리딘-6-일)-4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로이소퀴놀린 및 이의 용도 | |
WO2007135120A1 (en) | Novel 1,4-diaza-bicyclo[3.2.2]nonane derivatives and their medical use | |
SK127699A3 (en) | 2,3-dihydrofuro[3,2-b]pyridin, preparation and application thereof in therapy | |
US8557819B2 (en) | Derivatives of 5-pyridazinyl-1-azabicyclo[3.2.1]octane, preparation method thereof and use of same in therapeutics | |
EP0457243A1 (en) | Novel tricyclic compounds | |
JP2009505971A (ja) | 5−ピリジニル−1−アザビシクロ[3.2.1]オクタンの誘導体、この調製方法および治療におけるこの使用 | |
US6656951B2 (en) | 8-aza-bicyclo[3.2.1]octan-3-ol derivatives of 2,3-dihydro-1,4-benzodioxan as 5-HT1A antagonists | |
US20100076011A1 (en) | Enantiomer-Pure Hexahydro-Pyrrolocyclopenta-Pyridine Derivatives | |
CZ200030A3 (cs) | Deriváty 6-pyrrolidin-2-ylpyrindinů, způsob jejich přípravy a farmaceutický prostředek, který je obsahuje |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Patent lapsed due to non-payment of maintenance fees |
Effective date: 20150301 |